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Summary
Objective: Pathological mineralization is induced by unbalance between pro- and anti-mineralization factors. In calcifying osteoarthritic joints,
articular chondrocytes undergo terminal differentiation similar to that in growth plate cartilage and release matrix vesicles (MVs) responsible for
hydroxyapatite (HA) or calcium pyrophosphate dihydrate (CPPD) deposition. Inorganic pyrophosphate (PPi) is a likely source of inorganic
phosphate (Pi) to sustain HA formation when hydrolyzed but also a potent inhibitor preventing apatite mineral deposition and growth. More-
over, an excess of PPi can lead to CPPD formation, a marker of pathological calciﬁcation in osteoarthritic joints. It was suggested that the
Pi/PPi ratio during biomineralization is a turning point between physiological and pathological mineralization. The aim of this work was to de-
termine the conditions favoring either HA or CPPD formation initiated by MVs.
Methods: MVs were isolated from 17-day-old chicken embryo growth plate cartilages and subjected to mineralization in the presence of var-
ious Pi/PPi ratios. The mineralization kinetics and the chemical composition of minerals were determined, respectively, by light scattering and
infrared spectroscopy.
Results: The formation of HA is optimal when the Pi/PPi molar ratio is above 140, but is completely inhibited when the ratio decreases below
70. The retardation of any mineral formation is maximal at Pi/PPi ratio around 30. CPPD is exclusively produced by MVs when the ratio is
below 6, but it is inhibited for the ratio exceeding 25.
Conclusions: Our ﬁndings are consistent with the Pi/PPi ratio being a determinant factor leading to pathological mineralization or its inhibition.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Abbreviations: AnxA2eA6 vertebrate annexin 2e6, AMP adenosine monophosphate, 50AMPase 50 adenosine monophosphatase, ATP aden-
osine triphosphate, ATPase adenosine triphosphatase, BCIP bromo-chloro-indolyl phosphate, bis-p-NPP bis-p-nitrophenyl phosphate, CPPD
calcium pyrophosphate dihydrate, GPI glycosylphosphatidylinositol, HA hydroxyapatite, MVs matrix vesicles, NBT nitroblue tetrazolium, NPP1
nucleoside triphosphate pyrophosphatase phosphodiesterase 1, PAGE polyacrylamide gel electrophoresis, PDE phosphodiesterase, PI-PLC
phosphatidylinositol speciﬁc phospholipase C, PME phosphomonoesterase, pMV pellet of MVs treated by PI-PLC, p-NPP p-nitrophenyl phos-
phate, Pi inorganic phosphate, PPi inorganic pyrophosphate, SDS sodium dodecyl sulfate, SCL synthetic cartilage lymph, sMV supernatant of
MVs treated by PI-PLC, TNAP tissue non-speciﬁc alkaline phosphatase.Introduction
Physiological mineralization takes place during the forma-
tion and the development of mineralized tissues, e.g.,
bones and teeth1e3. In the prenatal and early postnatal
life, biomineralization is the last essential event in the endo-
chondral and intramembranous bone formation leading to
the replacement of cartilaginous skeleton and craniofacial*Address correspondence and reprint requests to: Dr Rene´
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64ﬁbrous tissue by the deﬁnitive bone skeleton. Throughout
life, the mineralization process continues to play a crucial
role in bone remodeling and repair. The regulation of phys-
iological mineralization is mediated at molecular, cellular
and tissue levels4 and involves coordination between stim-
ulatory and inhibitory factors3e6. However, uncontrolled or
pathological mineralization, due to an unbalance between
pro- and anti-mineralization factors3e6, can occur during
aging, degenerative joint diseases, or genetic and various
metabolic disorders. This causes an excessive mineral
deposition in articular cartilages7,8 that leads to joint inﬂam-
mation and the progression of osteoarthritis. Several calciﬁc
diseases are characterized by the deposit of calcium pyro-
phosphate dihydrate (CPPD) or of hydroxyapatite (HA) in
degenerative joints3e10.
65Osteoarthritis and Cartilage Vol. 17, No. 1During endochondral ossiﬁcation, chondrocytes undergo
a series of differentiation: cell proliferation, hypertrophy, ter-
minal differentiation and cell apoptosis11e14. Hypertrophic
chondrocytes initiate mineralization by releasing matrix
vesicles (MVs)14e16. MVs are involved in the initial step of
mineralization by promoting the formation of HA in their
lumen17. Preformed HA is released from MV into the extra-
cellular matrix, so that HA crystals continue to grow6. In
contrast, chondrocytes in healthy articular cartilage main-
tain a stable phenotype13 and their released MVs are un-
able to calcify6. These chondrocytes do not proliferate and
produce extracellular matrix components such as chondroi-
tin-4-sulfate, chondroitin-6-sulfate, keratansulfate, as well
as types II, III, VI, IX and XI collagen18.
Osteoarthritis is characterized by a degradation of the
proteoglycan and collagen matrix19 as well as by articular
chondrocytes undergoing terminal differentiation similar to
that in growth plate cartilage3. Osteoarthritic articular chon-
drocytes can release MVs20e23, which are responsible for
the initial formation of HA20e23 or CPPD minerals8,9,24,25
in degenerative joints. MVs from osteoarthritic cartilage
own similar protein machinery than MVs from growth plate
cartilage, necessary for Ca2þ uptakes into MV lumen:
annexin A2 (AnxA2), AnxA5 and AnxA626, as well as for in-
organic phosphate (Pi) homeostasis: tissue non-speciﬁc
alkaline phosphatase (TNAP)27,28, 50 adenosine monophos-
phatase (50AMPase)28, ion-motive adenosine triphospha-
tase (ATPases)28, and nucleotide pyrophosphatase/
phosphodiesterase-1 (NPP1)8,9,29. In addition to these pro-
teins, osteoarthritis articular chondrocytes express type X
collagen (a marker of hypertrophic chondrocytes), osteo-
nectin, bone morphogenetic proteins (which induce new
bone formation) and RUNX2 (a transcription factor regulat-
ing hypertrophic chondrocyte differentiation)26,30e32.
At enzymatic and molecular levels, NPP1 and TNAP have
antagonistic effects33e36 on mineral formation due to their
opposing activities: production of Inorganic pyrophosphate
(PPi) by NPP1 or its hydrolysis by TNAP. TNAP provides
Pi from various phosphate substrates during mineraliza-
tion37,38, whereas NPP1, and possibly TNAP39, supplies
PPi from adenosine triphosphate (ATP) or uridine triphos-
phate (UTP) hydrolysis. At low concentrations, PPi prevents
the seeding of calcium phosphate minerals40e44, while an
excessive accumulation of PPi in cartilagematrix leads to de-
posits of pathologic CPPD crystals, e.g., Ca2P2O7 2
H2O
45e47. Ankylosis protein (ANK), a transmembrane pro-
tein that transports intracellular PPi to the extracellular ma-
trix48e50, and NPP1, are overexpressed in chondrocytes of
osteoarthritic articular cartilage, contributing to increase
PPi, where CPPD crystal formation could occur
29,51e53.
Pi/PPi ratio could be a turning point to discern between
physiological and pathological mineralization and therefore
is subjected to tight regulation37. Since osteoarthritic MVs
and growth plate MVs exhibit similar structural and func-
tional properties, we selected MVs isolated from chick
embryo growth plate cartilage to determine the effect of
the Pi/PPi ratio on HA and CPPD depositions.Materials and methodsPURIFICATION OF MVSMVs were isolated from growth plate and epiphyseal cartilage slices of
17-day-old chicken embryos by collagenase digestion54, with slight modiﬁca-
tions55. Seventeen-day-old chicken embryo leg bones were cut into 1e3-mm
thick slices and washed ﬁve times in a synthetic cartilage lymph (SCL) con-
taining 100 mM NaCl, 12.7 mM KCl, 0.57 mM MgCl2, 1.83 mM NaHCO3,
0.57 mM Na2SO4, 1.42 mM NaH2PO4, 5.55 mM D-glucose, 63.5 mM sucroseand 16.5 mM N-tris(hydroxymethyl)methyl 2-aminoethane sulfonic acid
(TES) (pH 7.4). Growth plate and epiphyseal cartilage slices were digested
at 37C for 3.5e4 h in the SCL buffer with 1 mM Ca2þ and collagenase
(500 units/g of tissue, type IA, Sigma). It was vortexed and ﬁltered through
a nylon membrane. The suspension was centrifuged at 600 g for 10 min
to pellet intact hypertrophic chondrocytes. The supernatant was centrifuged
at 13,000 g for 20 min. The pellet was discarded and the supernatant was
submitted to a third centrifugation at 70,000 g for 1 h. The ﬁnal pellet con-
taining MVs was suspended in 300 mL of SCL buffer and stored at 4C. The
protein concentration in the MV fraction was determined using the Bradford
assay kit (Bio-Rad). Proteins of MVs were separated in 7.5 or 10% (w/v) so-
dium dodecyl sulfate (SDS)-polyacrylamide gels56. The gels were stained
with Coomassie Brilliant Blue R-250.TRANSMISSION ELECTRON MICROSCOPYA 20 mL aliquot of MV fraction was transferred to carbon-coated grids. The
grids were negatively stained with 2% uranyl acetate and dried. The grids
were viewed with an electron microscope Philips CM140 at 80 kV accelerat-
ing voltage.TREATMENT OF MVS BY PHOSPHATIDYLINOSITOL SPECIFIC
PHOSPHOLIPASE CMVs (1 mg of MV proteins/mL) were incubated in SCL with 10 mM Mg2þ,
5 mM Zn2þ and 1 unit of phosphatidylinositol speciﬁc phospholipase C (PI-
PLC) per mL for 7 h at 37C under gentle agitation. The supernatant of
MVs (sMVs) treated by PI-PLC containing MV glycosylphosphatidylinositol
(GPI)-anchored proteins and the pellet (pMV) were separated by centrifuga-
tion at 90,000 g for 30 min. The pellet of MVs treated by PI-PLC (pMV) was
resuspended in the same volume of SCL as before the centrifugation.IMMUNODETECTION OF CHICKEN CAVEOLIN-1Proteins of MVs were separated in 12% (w/v) SDS-polyacrylamide gels56
and then electro-transferred (Mini-ProteanIIKit, Bio-Rad) onto nitrocellulose
membranes (HybondeECL, Amersham Biosciences)57. The nitrocellu-
lose membranes were blocked with 5% (w/v) milk in a buffer (20 mM Tri-
seHCl, pH 7.5, 150 mM NaCl) for 1 h at room temperature, then incubated
with 3% (w/v) milk and 0.1% (v/v) mousemonoclonal IgG against chicken cav-
eolin-1 (BD Biosciences) in tween 20 tris buffered saline (TTBS) buffer
(20 mM TriseHCl, pH 7.5, 150 mM NaCl, 0.05% (v/v) Tween 20) at 4C over-
night. The nitrocellulose membranes were washed several times with TTBS
and incubated with 3% (w/v) milk and 0.05% (v/v) goat anti-mouse IgG conju-
gated with alkaline phosphatase (Immuno-Blot Assay Kit, Bio-Rad) in TTBS
buffer. The membranes were washed, and bands were visualized by addition
of color-developing solution according to the manufacturer’s instructions.SPECIFIC REVELATION OF ALKALINE PHOSPHATASEMV proteins were incubated under mild denaturing conditions (without
heating before the gel migration) in the Tris buffer containing 2% SDS but
no b-mercaptoethanol to preserve the TNAP activity. After the migration,
SDS-polyacrylamide gels were incubated in a solution containing 0.1 M
TriseHCl (pH 9.6), 0.1 M NaCl, 5 mM MgCl2, 0.24 mM bromo-chloro-indolyl
phosphate (BCIP), a TNAP substrate and 0.25 mM nitroblue tetrazolium
(NBT) until the blue band associated to alkaline phosphatase was visible39.ENZYMATIC ASSAYSThe phosphomonoesterase (PME) activity was measured at pH 7.4 or
10.4, using 10 mM p-nitrophenyl phosphate ( p-NPP) as a substrate58, in
25 mM piperazine and 25 mM glycylglycine buffer, by monitoring the release
of p-nitrophenolate at 420 nm (3¼ 9.2 cm1 mM1 at pH 7.4;
3¼ 18.5 cm1 mM1 at pH 10.4, M1). One unit of PME activity corresponds
to the amount of enzyme hydrolyzing 1 mmol of p-NPP per minute at 37C.
The phosphodiesterase (PDE) activity of MVs was measured at pH 7.4 or
at 9, with 2 mM bis-p-nitrophenyl phosphate (bis-p-NPP) as substrate in
25 mM piperazine and 25 mM glycylglycine buffer, and monitoring the re-
lease of p-nitrophenolate at 420 nm (3¼ 9.2 cm1 mM1 at pH 7.4;
3¼ 17.8 cm1 mM1 at pH 9)39. One unit of PDE activity corresponds to
the amount of enzymes hydrolyzing 1 mmol of bis-p-NPP per minute at
37C. To determine the pyrophosphatase activity, MVs were incubated in
25 mM piperazine and 25 mM glycylglycine buffer (at the indicated pH) con-
taining 0.25e2 mM PPi, for 20 min at 37
C. The reaction was stopped by
adding 10 mM levamisole and stored at 4C. Aliquots of the reaction mixture
were collected to determine PPi concentrations with the Sigma reagent kit.
One unit of pyrophosphatase activity corresponds to the amount of enzymes
hydrolyzing 1 mmol of PPi per minute at 37
C.
66 C. Thouverey et al.: Regulating effect of PPi on mineralizationDETERMINATION OF MINERALIZATION KINETICSAliquots of the MV stock solution were diluted to a ﬁnal concentration of
20 mg of MV proteins/mL in the SCL buffer containing 2 mM Ca2þ and differ-
ent concentrations of ions (Pi, PPi) or phosphate substrates [adenosine
monophosphate (AMP), ATP], as indicated in the ﬁgure legends. They
were incubated at 37C and their absorbances at 340 nm were measured
at 15-min intervals with Uvikon spectrophotometer model 932 (Kontron In-
struments). When MVs were incubated in SCL containing 2 mM Ca2þ but
not Pi, PPi and other phosphate substrates, there were no changes in turbid-
ity. Thus, the increase in turbidity was due to mineral formation59,60.IDENTIFICATION OF MINERALS BY INFRARED
SPECTROSCOPYThe minerals were determined by infrared spectroscopy (Nicolet 510M
FTIR spectrometer). They were centrifuged at 3,000 g for 10 min and
washed several times with water. They were dried and incorporated by
pressing into 100 mg of KBr. Standard CPPD was prepared by incubating
stoichiometric proportions of Ca2þ and PPi at 37C for 2 weeks. Standard
HA was purchased from Sigma.ResultsBIOCHEMICAL CHARACTERIZATION OF MVSThe MVs extracted from chicken embryo growth plate
cartilages were round structures with a diameter rangingFig. 1. Electron microscope view of MVs. MVs exhibit spherical sha
B, 100,000; C, 75,00from 100 to 250 nm (Fig. 1), in agreement with Anderson
et al.61 and Balcerzak et al.55. The electrophoresis proﬁle
of MVs exhibited, among others, three major bands with ap-
parent molecular weights of 44, 38 and 31 kDa [Fig. 2(A)]59.
Caveolin-1, a marker of caveolae, present in the plasma
membrane of hypertrophic chondrocytes [26 kDa,
Fig. 2(B), lane 2], was absent in MVs [Fig. 2(B), lane 1],
indicating that isolated MVs are not contaminated by the
fragments of plasma membrane. TNAP, a marker enzyme
of MVs62, involved in the Pi homeostasis in mineralizing
tissues63e65, was enriched in the MV fractions. The PME
activity associated with TNAP of MVs at pH 10.4 was 25.0
 3.4 units/mg of proteins, approximately ﬁve times higher
in comparison to hypertrophic chondrocytes (Table I),
indicating a high degree of purity of MV preparations.EXTRAVESICULAR PI AND PPI HOMEOSTASIS BY MVSTo delineate the importance of TNAP in PME and pyro-
phosphatase activities of MVs, the enzyme was digested
out from MVs by a cleavage of its GPI anchor with PI-
PLC. GPI-anchored TNAP in untreated MVs exhibited an
apparent molecular weight of 118 kDa (Fig. 3, lane 1). After
centrifugation, TNAP without GPI anchor was detected in
the supernatant (sMV, Fig. 3, lane 2), but not in the pelletpes with a 100e250 nm diameter (magniﬁcations: A, 53,000;
0; D, 100,000).
Fig. 2. (A) Protein pattern of MVs in a 10% SDS-polyacrylamide gel.
Lane 1, MVs. (B) Western-Blot of MVs and hypertrophic chondro-
cytes for the detection of caveolin-1. Lane 1, MVs; Lane 2, co-
isolated chondrocytes.
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Fig. 3, lane 3). The speciﬁc PME activity of MVs amounted
to 0.62 0.10 units/mg of MV proteins at physiological pH,
e.g., 40 times lower than at pH 10.4 (Table II). The percent-
age of total PME activity of the sMV was 92 3.7% at pH
10.4 and 91 3% at pH 7.4 (Table II), indicating that
more than 91% of PME activity is associated with TNAP
in MVs. The PDE activity of MVs reﬂecting both TNAP39
and NPP1 activities35 was 2.66 0.30 units/mg of MV pro-
teins at optimal conditions (pH 9). It was 0.52 0.08 units/
mg of MV proteins at pH 7.4. When the substrate concentra-
tion was reduced from 2 to 0.5 mM, the optimal pH for the
activity shifted from 8.8 to 8.2 (Fig. 4). In the presence of
2 mM PPi, the pyrophosphatase activity of MVs was
3.70 0.31 units/mg of MV proteins at pH 8.8, and
1.00 0.08 units/mg of MV proteins at physiological pH
(Table II). The apparent Km of PPi hydrolysis at physiologi-
cal pH was identical for MVs, sMV and pMV, and amounted
to 355 6 mM. The pyrophosphatase activity of all these
samples was also inhibited in the same competitive manner
by Pi; Ki amounted to 3.63 0.14 mM. Over 96 5.2% of
the pyrophosphatase activity was attributed to the sMV at
pH 7.4 (Table II), indicating that the ability of MVs to hydro-
lyze PPi was due to TNAP.PI AND NUCLEOTIDE-INITIATED MINERALIZATION BY MVSThe isolated MVs, incubated in the SCL buffer with 2 mM
Ca2þ were able to induce mineral formation, after a short
lag period of 3.5e4 h, corresponding to the time of accumu-
lation of Ca2þ and Pi within MVs
60. Then, the mineral forma-
tion increased rapidly and reached saturation (Fig. 5). MVsTable
Preparation of MVs from femoral and tibial growth plate cartilages of 17-d
lagenase. Hypertrophic chondrocytes were obtained by a centrifugatio
13,000 g for 20 min and MVs by a last centrifugation at 70,000 g for
per minute, per mg of MV
Digest Hypertrophic chond
Speciﬁc PME activity (units/mg) 2.1 0.2 5.2 0.8
Percentage of total
activity (%)
100 18.2 2.7
Enrichment 1 2.5in SCL medium without Ca2þ were not able to mineralize,
indicating that the presence of 0.57 mM Mg2þ in SCL
medium containing MVs cannot induce mineral formation.
No mineral was formed in the SCL buffer with 2 mM Ca2þ
devoid of MVs, indicating that MVs are essential to initiate
mineralization.
The MV-induced mineral was identiﬁed by infrared spec-
troscopy. The infrared spectrum of mineral formed by MVs
in SCL buffer exhibited ﬁve peaks at 1090 cm1,
1030e1034 cm1, 960e961 cm1, 600e602 cm1 and
561e562 cm1 (Fig. 6, spectrum: SCL), corresponding to
the peaks of HA (Fig. 7, spectrum: HA)66,67, indicating the
ability of MVs to produce HA. Addition of 1 mM or 2 mM
Pi (corresponding, respectively, to a total Pi concentration
of 2.42 mM or 3.42 mM in SCL) into the mineralization me-
dium reduced the lag period of mineral formation induced by
MVs from 3.5e4 h to 1.5e2 h or to 0.5 h, respectively
(Fig. 5). In both cases, the minerals formed by MVs were
identiﬁed as crystalline HA (Fig. 6, spectrum: Pi). Addition
of 1 mM AMP reduced the induction phase from 3.5e4 h
to 2.5e3 h (Fig. 5), i.e., to a lower extent as compared
with the addition of 1 mM Pi, due to the time required for hy-
drolysis of AMP by TNAP. The mineral formed was also HA
(Fig. 6, spectrum: AMP). However, addition of 0.33 mM
ATP, increased the time delay of mineral formation from
3.5e4 h to 18e20 h (Fig. 5). This retardation was due to
the inhibitory effect of ATP on HA deposition68 or the forma-
tion of PPi, a potent inhibitor of calciumephosphate deposi-
tion41e43. The mineral phase produced by MVs in the
presence of 0.33 mM ATP revealed HA and a small amount
of other minerals, as suggested by the presence of a broad
contour in the 1200e1000 cm1 region (Fig. 6, spectrum:
ATP), and as reported elsewhere37.THE REGULATORY EFFECT OF PPI ON BIOMINERALIZATIONTo identify the conditions to produce HA or other min-
erals, MVs were incubated in the SCL buffer with 2 mM
Ca2þ, Pi at 1.42e3.42 mM concentration range and PPi at
0.01e2.41 mM concentration range. Pi/PPi ratio was calcu-
lated initially and during the induction phase of mineraliza-
tion since PPi was continuously hydrolyzed and both Pi
and PPi were involved in the mineral formation. The ﬁnal
Pi/PPi ratio was determined for each initial Pi/PPi ratio.
The initial Pi/PPi ratio (within 1.42e3.42 mM Pi and
0.01e2.41 mM PPi) predetermined the type of mineral
formed by MVs. Without PPi, the period of induction phase
was about 3 h when MVs were incubated in the SCL buffer
with 2 mM Ca2þ [Fig. 8(A)], and 0.5 h when the SCL buffer
was supplemented by 2 mM Ca2þ and 2 mM Pi correspond-
ing to a total amount of 3.42 mM Pi in SCL [Fig. 8(B)]. A
higher amount of Pi decreased the induction time of mineral
formation. MVs incubated in the presence of Ca2þ and Pi
formed crystalline HA (Fig. 9, spectrum I). The inductionI
ay-old chick embryos. Growth plate cartilages were digested by col-
n at 600 g for 10 min, the second pellet by a centrifugation at
60 min. PME activity is expressed as mmol of p-NPP hydrolyzed
proteins at pH 10.4
rocytes Second pellet MVs Last supernatant
5.7 0.6 25.0 3.4 0.3 0.1
34.4 3.5 39.7 3.6 11.1 1.1
2.7 11.9 0.1
Fig. 3. BCIPeNBT visualization of TNAP in a 7.5% SDS-polyacryl-
amide gel. Lane 1, MVs; Lane 2, sMV (supernatant of MVs treated
by PI-PLC); Lane 3, pMV. Fig. 4. The effect of pH on the PPi hydrolysis by MVs. The pyro-
phosphatase activity of MVs was measured at different pH from 7
to 11, in the presence of different concentrations of PPi: (-)
2 mM, (C) 1 mM, and (:) 0.5 mM.
68 C. Thouverey et al.: Regulating effect of PPi on mineralizationtime of mineralization increased from 3 to 6 h [Fig. 8(A)] af-
ter addition of 0.01 mM PPi into the SCL medium with 2 mM
Ca2þ (since SCL medium contained 1.42 mM Pi, the initial
Pi/PPi ratio was 142 47 and ﬁnal Pi/PPi ratio was
198.3 65.6, Table III). Addition of 0.024 mM PPi
and 2 mM Pi in SCL (total Pi was 3.42 mM in SCL medium;
initial Pi/PPi ratio was 142 47 and ﬁnal Pi/PPi ratio was
198.3 65.6), increased the induction time of mineraliza-
tion from 0.5 to 2.5 h [Fig. 8(B)] and the mineral
formed was crystalline HA (Fig. 9, spectrum II). At the initial
Pi/PPi ratio between inﬁnite and 142 47, the induction
time increased (Table III), but the mineral formed was al-
ways HA (Table III). The turning point where the mineral
phase contained a mixture of poorly crystalline HA and
other minerals, was reached with an initial Pi/PPi ratio of
71 14.2 (Table III). The maximal induction time of mineral
formation occurred upon addition of 0.05 0.01 mM PPi in
SCL with 1.42 mM total Pi concentration [18 h, Fig. 8(A)]
or 0.12 mM PPi in SCL with 3.42 mM total Pi concentration
[10 h, Fig. 8(B)], corresponding for both to an initial Pi/PPi
ratio of 28.4 5.7 [Fig. 8(C)] and to a ﬁnal Pi/PPi ratio of
102.9 20.7 (Table III). The minerals formed under these
conditions were not HA as evidenced by the absence of
characteristic HA bands at 960e961 cm1, 600e601 cm1
and 560e562 cm1. Amorphous mixtures were produced
(Fig. 9, spectrum III). The induction time of mineral forma-
tion decreased with the diminution of initial Pi/PPi ratio
from 28.4 5.7, indicating faster mineral formation. AdditionTable II
Hydrolysis of p-NPP and PPi by MVs, the supernatant fraction
(sMV) and the pellet fraction (pMV) of MVs treated by PI-PLC.
PME activity was measured by hydrolysis of p-NPP at pH 10.4
(PME10.4) and at pH 7.4 (PME7.4). Pyrophosphatase activity was
determined by hydrolysis of PPi at pH 8.8 (PPi8.8) and at pH 7.4
(PPi7.4). The activities of MVs are expressed as mmol of substrate
hydrolyzed per minute, per mg of MV proteins, under described
conditions. The activities of sMV and pMV are expressed as per-
centages of total MV activities
MVs (units/mg) % of total MV activity
sMV pMV
PME10.4 25.0 3.40 92.0 3.7 9.8 0.9
PME7.4 0.62 0.10 91.0 3.0 12.0 1.0
PPi8.8 3.70 0.31 95.2 2.8 6.0 1.0
PPi7.4 1.00 0.09 96.0 1.7 5.2 0.8of 0.1 mM PPi in SCL with 1.42 mM total Pi concentration
(initial Pi/PPi ratio of 14.2 1.4 and ﬁnal Pi/PPi ratio of
24.5 2.4) reduced the induction time of mineral formation
to 9 h. It was further reduced to 7 h with the addition of
0.5 mM PPi (initial Pi/PPi ratio of 2.8 0.3 and ﬁnal ratio
of 6.2 0.7) and to 5 h with 1 mM PPi (initial Pi/PPi ratio
of 1.4 0.1 and ﬁnal ratio of 2.8 0.3) [Fig. 8(A)]. We
observed also a decrease of induction time of mineral for-
mation at the same Pi/PPi ratio but with higher PPi concen-
trations in SCL medium containing 3.42 mM Pi [Fig. 8(B)].
Due to the higher amount of PPi and Pi, there was a higher
amount of mineral formed as evidenced by the larger turbid-
ity and the kinetics [Fig. 8(B) vs Fig. 8(A)]. Although the
mineral formation in MVs was stimulated with higher con-
centrations of PPi, the nature of mineral deposits was differ-
ent. At the initial Pi/PPi ratios between 14.2 1.4 and
2.8 0.3, the mineral phase was composed of a mixtureFig. 5. Kinetics of mineral formation by MVs. MVs were incubated at
37C in SCL buffer containing 2 mM Ca2þ and 1.42 mM Pi with ad-
ditional Pi or phosphate substrates, as follows: (;) without addi-
tional substrates, (<) total Pi¼ 2.42 mM, (:) total Pi¼ 3.42 mM,
(,) 1 mM AMP, and (>) 0.33 ATP. Mineral formation was
assessed by light scattering at 340 nm.
Fig. 6. Infrared spectra of minerals formed by MVs in the presence
of different concentrations of Pi or different phosphate substrates.
MVs were incubated at 37C in SCL buffer containing 2 mM Ca2þ
and 1.42 mM Pi with additional Pi or phosphate substrates: without
addit ional substrates as a control (spectrum SCL), total
Pi ¼ 3.42 mM (spectrum Pi), 1 mM AMP (spectrum AMP), 0.33
ATP (spectrum ATP).
Fig. 7. Infrared spectra of HA and CPPD standards.
Fig. 8. Retardation of PPi-initiated mineral formation. (A) MVs were incub
PPi at various concentrations: (;) without additional PPi, (<) 0.01 mM,
sponding to an initial Pi/PPi ratio of 142, 28.4, 14.2, 2.8, and 1.4, respe
2 mM Ca2þ, 3.42 mM Pi and different concentrations of PPi: (;) withou
1.2 mM and (B) 2.41 mM PPi, corresponding to the same Pi/PPi ratio
percentages of the maximal retardation
69Osteoarthritis and Cartilage Vol. 17, No. 1of minerals, including CPPD (Fig. 9, spectrum IV), as char-
acterized by the appearance of the characteristic CPPD
bands at 1140 cm1, 925 cm1, 725 cm1 and 555 cm1
(Fig. 7, spectrum: CPPD). At the initial Pi/PPi ratio lower
than 2.8 0.3, the spectrum of the mineral formed by
MVs resembled to CPPD (Fig. 9, spectrum V). CPPD min-
eral was exclusively produced by MVs when the initial Pi/
PPi ratio was lower than 1.4 0.1 (Fig. 9, spectrum VI).ated at 37C in SCL buffer containing 2 mM Ca2þ, 1.42 mM Pi and
(:) 0.05 mM, (,) 0.1 mM, (>) 0.5 mM and (B) 1 mM PPi corre-
ctively. (B) MVs were incubated at 37C in SCL buffer containing
t additional PPi, (<) 0.024 mM, (:) 0.12 mM, (,) 0.24 mM, (>)
as in panel A. (C) All results were combined and normalized as
of mineralization induced by PPi.
Fig. 9. Infrared spectra of minerals produced by MVs at different Pi/
PPi molar ratios: (I) no PPi, (II) 142, (III) 28.4, (IV) 14.2, (V) 2.8 and
(VI) 1.4. MVs were incubated at 37C in SCL buffer containing
2 mM Ca2þ, 3.42 mM Pi and PPi at 0, 0.024 mM, 0.12 mM,
0.24 mM, 1.2 mM or 2.41 mM.
70 C. Thouverey et al.: Regulating effect of PPi on mineralizationUnder the same conditions, no CPPD was formed in SCL
medium without MVs.Discussion
Our report focused on the conditions favoring HA and
CPPD minerals induced by MVs from growth plate carti-
lage. MVs were used to mimic pathological calciﬁcation,
since the initiation of mineral formation mediated by
MVs during endochondral calciﬁcation is similar to that
which appears in a variety of pathologic calciﬁcation6. Al-
though MV model has the disadvantage that matrix and
cellular issues cannot be addressed, it provides an easilyTable III
The effect of the Pi/PPi ratio on the mineralization mediated by
MVs. MVs were incubated in the SCL buffer containing 2 mM
Ca2þ, Pi at 1.42e3.42 mM concentration range and PPi at
0.01e2.41 mM concentration range. Initial Pi/PPi ratios and Pi/PPi
ratios prior to the onset of calcification were calculated. The kinetics
of mineralization was followed by light scattering at 340 nm and the
minerals formed by MVs were identified by infrared spectroscopy
(the numbering of spectra corresponded to the infrared spectra in
Fig. 9 and to the minerals formed at a specific Pi/PPi ratio as indi-
cated in the table). Induction time was the longest (100%) at initial
[Pi]/[PPi]¼ 28.4 5.7 and the lowest (12.5 1.4) in the absence of
PPi
Initial
[Pi]/[PPi]
Final
[Pi]/[PPi]
Induction
time (%)
Minerals formed,
IR spectra in Fig. 9
N N 12.5 1.4 HA, Spectrum I
142 47 198.3 65.6 33.4 5.6 HA, Spectrum II
71 14.2 138.7 27.7 50.1 3.5 HAþ other
28.4 5.7 102.9 20.7 100 5.0 CPPDþ other,
Spectrum III
14.2 1.4 24.5 2.4 68.1 4.2 CPPDþ other,
Spectrum IV
2.8 0.3 6.2 0.7 51.4 4.2 CPPD, Spectrum V
1.4 0.1 2.8 0.3 30.1 2.8 CPPD, Spectrum VIquantiﬁable and well-characterized model to analyze the
initiation of HA or CPPD formation47. MVs served to
model arthritic crystal deposition characterized by HA or
CPPD deposits in joint cartilage. In the absence of inhib-
itors, Ca2þ/Pi ratio and the Ca
2þ Pi product are critical
factors affecting the kinetics of the biomineralization pro-
cess69. Increasing the Pi concentration (Fig. 5) and addi-
tion of phosphomonoester substrates of TNAP, such as
AMP, reduced the induction time of HA formation
(Fig. 5). However, addition of ATP, another source of Pi
after its hydrolysis, led to a high retardation of the induc-
tion phase of mineralization (Fig. 5) and to a mixture of
poorly crystalline HA and other minerals (Fig. 3, spec-
trum: ATP), consistent with Zhang et al.39. The retarda-
tion was due to the inhibitory effect of ATP68 or
PPi
41e43, on the HA formation. ATP is a source of Pi
(after its hydrolysis by TNAP, ATPases and other PME
enzymes) but also a source of PPi after its hydrolysis
by NPP1 and TNAP39. PPi, when hydrolyzed, provides
Pi for HA formation but inhibits the seeding of
calciumephosphate minerals itself. In addition, high con-
centrations of PPi led to the precipitation of immature
CPPD mineral. Alternatively, metastable equilibrium be-
tween Ca2þ, Pi and PPi can be disturbed, inducing min-
eral formations without MVs. Cheng and Pritzker70
reported that HA was formed in aqueous solution when
Pi/PPi was higher than 100, while CPPD was produced
when Pi/PPi was less than 3. MVs from growth plate car-
tilages are able to produce CPPD minerals37,71. Since os-
teoarthritic MVs and growth plate MVs own similar protein
machinery associated with mineralization, these ﬁndings
underline a mechanism of CPPD pathological deposit.
Our data emphasize that not only PPi concentration af-
fected the nature of the formed mineral but also the Pi/
PPi ratio is a key parameter to favor HA or CPPD forma-
tion as proposed previously37. The Pi/PPi ratio is a deter-
minant factor leading to pathological mineralization or its
inhibition. Initial Pi/PPi ratio higher than 140 led to HA de-
position, mimicking conditions during endochondral bone
formation or arthritic crystal deposition. When Pi/PPi ratio
was lower than 70, it inhibited the MV-induced seeding of
HA, which corresponds to the conditions where minerali-
zation is inhibited. An initial Pi/PPi ratio lower than 2.8
led to deposits of pathological CPPD, while initial Pi/PPi
ratio higher than 28.4 inhibited CPPD formation. The Pi/
PPi ratio could reﬂect somehow the overall differentiation
states of chondrocytes (mature vs hypertrophic), the
levels of expression of TNAP, NPP1 or other proteins af-
fecting Pi and PPi concentrations as well as the balance
between pro- and anti-calciﬁcation factors and may serve
as an indicator of calciﬁcation process.Conﬂict of interest
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